BIVI - Biovie Inc

BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States. The company is headquartered in Santa Monica, California.

52W High

$44.80

52W Low

$1.42

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.86

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-11.66

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

0.69

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

3.28%

Institutions (25–75% balanced)

1.53%

Shares Outstanding

7,534,200

Float

7,500,500

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-12.12

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-1.02%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

-0.6766

-0.7411

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025